Risk with  -blocking in bronchial asthma.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000328:Adult; D000605:Amino Alcohols / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011437:Propylamines / Q000009:adverse effects; D013565:Sympatholytics / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines; D013565:Sympatholytics